Trial Summary
What is the purpose of this trial?
The goal of this single arm study is to evaluate the effectiveness of Wesper Lab, previously known as TatchSleep Pro, a wireless home sleep test, as a tool to aid in sleep apnea diagnosis as compared to an overnight polysomnography (PSG) evaluation in a pediatric population (subjects 2 to 21 years of age). The main question\[s\] it aims to answer are: * Does Wesper Lab demonstrate agreement with PSG for the calculation of the apnea/hypopnea index (AHI)? * Does Wesper Lab demonstrate agreement with PFG for the calculation of sleep apnea severity. Participants that are already undergoing a prescribed PSG for the detection of sleep apnea will be asked to simultaneously wear the Wesper Lab sensors and an FDA approved pulse oximeter. Researchers will compare the AHI of Wesper Lab to the AHI of the PSG to determine the accuracy of the Wesper Lab device. This is a single center, single-arm, quantitative study
Research Team
German P Digoy, M.D.
Principal Investigator
Associate Professor of Otolaryngology, Oklahoma State University Center for Health Sciences
Eligibility Criteria
This trial is for children and young adults aged 2 to 21 who are already scheduled for a standard sleep study (PSG) to check for sleep apnea. Participants will use the Wesper Lab home test at the same time as their regular PSG.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Wesper Lab (Medical Device)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tatch Inc.
Lead Sponsor
Wesper Inc
Lead Sponsor
Wasper Inc
Lead Sponsor